Takeda Pharmaceutical Company Limited
TAK
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived therapies, oncology, and neuroscience. The company proā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
16 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$18.60
Price+0.27%
$0.05
1Y
Price
Market Cap
$58.745b
Large
Price/Earnings 3y Avg5y Avg
80.9x
Premium
Premium
Financial Reports
Key metrics over the past few years and other important metrics. Amounts in JPY.+37.6%
EBITDA Margin+8.7%
Net Profit Margin+26.2%
Free Cash Flow Margin+37.6%
EBITDA Margin+8.7%
Net Profit Margin+26.2%
Free Cash Flow MarginRevenue
$4.486t
-2.1%
1y CAGR+3.8%
3y CAGR+6.0%
5y CAGREarnings
$114.751b
+6.3%
1y CAGR-24.4%
3y CAGR-8.9%
5y CAGREPS
$35.68
+6.1%
1y CAGR-25.0%
3y CAGR-9.1%
5y CAGRBook Value
$7.649t
$15.419t
Assets$7.770t
Liabilities$4.857t
DebtDebt to Assets
31.5%
3.5x
Debt to EBITDAFree Cash Flow
$956.593b
+11.7%
1y CAGR+81.3%
3y CAGR+45.1%
5y CAGRNo items found.
Press Releases
Statements and updates from the company